% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I183934855
% 33 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{sims2017-28714976,
  author  = {Sims, R. and van der Lee, S. J. and Naj, A. C. and Bellenguez, C. and Badarinarayan, N. and Jakobsdottir, J. and Kunkle, B. W. and Boland, A. and others},
  title   = {{Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease}},
  journal = {Nature genetics},
  year    = {2017},
  doi     = {10.1038/ng.3916},
  pmid    = {28714976},
  url     = {https://doi.org/10.1038/ng.3916}
}

@article{ostrowitzki2022-36121669,
  author  = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others},
  title   = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2909},
  pmid    = {36121669},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2909}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{teng2022-35696185,
  author  = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others},
  title   = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.1375},
  pmid    = {35696185},
  url     = {https://doi.org/10.1001/jamaneurol.2022.1375}
}

@article{ostrowitzki2017-29221491,
  author  = {Ostrowitzki, S. and Lasser, R. A. and Dorflinger, E. and Scheltens, P. and Barkhof, F. and Nikolcheva, T. and Ashford, E. and Retout, S. and others},
  title   = {{A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2017},
  doi     = {10.1186/s13195-017-0318-y},
  pmid    = {29221491},
  url     = {https://doi.org/10.1186/s13195-017-0318-y}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{cummings2018-29695589,
  author  = {Cummings, J. L. and Cohen, S. and van Dyck, C. H. and Brody, M. and Curtis, C. and Cho, W. and Ward, M. and Friesenhahn, M. and others},
  title   = {{ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005550},
  pmid    = {29695589},
  url     = {https://doi.org/10.1212/wnl.0000000000005550}
}

@article{monteiro2023-37643887,
  author  = {Monteiro, C. and Toth, B. and Brunstein, F. and Bobbala, A. and Datta, S. and Ceniceros, R. and Sanabria Bohorquez, S. M. and Anania, V. G. and others},
  title   = {{Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207663},
  pmid    = {37643887},
  url     = {https://doi.org/10.1212/wnl.0000000000207663}
}

@article{long2024-39444037,
  author  = {Long, H. and Simmons, A. and Mayorga, A. and Burgess, B. and Nguyen, T. and Budda, B. and Rychkova, A. and Rhinn, H. and others},
  title   = {{Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01599-1},
  pmid    = {39444037},
  url     = {https://doi.org/10.1186/s13195-024-01599-1}
}

@article{benitez2014-24439484,
  author  = {Benitez, B. A. and Jin, S. C. and Guerreiro, R. and Graham, R. and Lord, J. and Harold, D. and Sims, R. and Lambert, J. C. and others},
  title   = {{Missense variant in TREML2 protects against Alzheimer's disease}},
  journal = {Neurobiology of aging},
  year    = {2014},
  doi     = {10.1016/j.neurobiolaging.2013.12.010},
  pmid    = {24439484},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2013.12.010}
}

@article{salloway2018-30231896,
  author  = {Salloway, S. and Honigberg, L. A. and Cho, W. and Ward, M. and Friesenhahn, M. and Brunstein, F. and Quartino, A. and Clayton, D. and others},
  title   = {{Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)}},
  journal = {Alzheimer's research \& therapy},
  year    = {2018},
  doi     = {10.1186/s13195-018-0424-5},
  pmid    = {30231896},
  url     = {https://doi.org/10.1186/s13195-018-0424-5}
}

@article{soldan2025-39724536,
  author  = {Soldan, A. and Pettigrew, C. and Wang, J. and Albert, M. S. and Blennow, K. and Bittner, T. and Moghekar, A.},
  title   = {{Blood-Based Biomarkers and Risk of Onset of Mild Cognitive Impairment Over the Short and Long Term}},
  journal = {Neurology},
  year    = {2025},
  doi     = {10.1212/wnl.0000000000210225},
  pmid    = {39724536},
  url     = {https://doi.org/10.1212/wnl.0000000000210225}
}

@article{jonsson2012-22801501,
  author  = {Jonsson, T. and Atwal, J. K. and Steinberg, S. and Snaedal, J. and Jonsson, P. V. and Bjornsson, S. and Stefansson, H. and Sulem, P. and others},
  title   = {{A mutation in APP protects against Alzheimer's disease and age-related cognitive decline}},
  journal = {Nature},
  year    = {2012},
  doi     = {10.1038/nature11283},
  pmid    = {22801501},
  url     = {https://doi.org/10.1038/nature11283}
}

@article{green2024-39198642,
  author  = {Green, G. S. and Fujita, M. and Yang, H. S. and Taga, M. and Cain, A. and McCabe, C. and Comandante-Lou, N. and White, C. C. and others},
  title   = {{Cellular communities reveal trajectories of brain ageing and Alzheimer's disease}},
  journal = {Nature},
  year    = {2024},
  doi     = {10.1038/s41586-024-07871-6},
  pmid    = {39198642},
  url     = {https://doi.org/10.1038/s41586-024-07871-6}
}

@article{kimura2025-40205047,
  author  = {Kimura, K. and Subramanian, A. and Yin, Z. and Khalilnezhad, A. and Wu, Y. and He, D. and Dixon, K. O. and Chitta, U. K. and Ding, X. and Adhikari, N. and Guzchenko, I. and Zhang, X. and others},
  title   = {{Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease}},
  journal = {Nature},
  year    = {2025},
  doi     = {10.1038/s41586-025-08852-z},
  pmid    = {40205047},
  url     = {https://doi.org/10.1038/s41586-025-08852-z}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{liss2021-33458891,
  author  = {Liss, J. L. and Seleri Assunção, S. and Cummings, J. and Atri, A. and Geldmacher, D. S. and Candela, S. F. and Devanand, D. P. and Fillit, H. M. and others},
  title   = {{Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis}},
  journal = {Journal of internal medicine},
  year    = {2021},
  doi     = {10.1111/joim.13244},
  pmid    = {33458891},
  url     = {https://doi.org/10.1111/joim.13244}
}

@article{dejanovic2022-37118504,
  author  = {Dejanovic, B. and Wu, T. and Tsai, M. C. and Graykowski, D. and Gandham, V. D. and Rose, C. M. and Bakalarski, C. E. and Ngu, H. and others},
  title   = {{Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models}},
  journal = {Nature aging},
  year    = {2022},
  doi     = {10.1038/s43587-022-00281-1},
  pmid    = {37118504},
  url     = {https://doi.org/10.1038/s43587-022-00281-1}
}

@article{hansen2017-29196460,
  author  = {Hansen, David V. and Hanson, Jesse E. and Sheng, Morgan},
  title   = {{Microglia in Alzheimer’s disease}},
  journal = {The Journal of Cell Biology},
  year    = {2017},
  doi     = {10.1083/jcb.201709069},
  pmid    = {29196460},
  url     = {https://doi.org/10.1083/jcb.201709069}
}

@article{yeh2016-27477018,
  author  = {Yeh, F. L. and Wang, Y. and Tom, I. and Gonzalez, L. C. and Sheng, M.},
  title   = {{TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia}},
  journal = {Neuron},
  year    = {2016},
  doi     = {10.1016/j.neuron.2016.06.015},
  pmid    = {27477018},
  url     = {https://doi.org/10.1016/j.neuron.2016.06.015}
}

@article{liu2023-38230712,
  author  = {Liu, Ying and Jun, Hankyung and Becker, A. and Wallick, Christopher J. and Mattke, Soeren},
  title   = {{Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2023},
  doi     = {10.14283/jpad.2023.131},
  pmid    = {38230712},
  url     = {https://doi.org/10.14283/jpad.2023.131}
}

@article{moscoso2025-11860bf1,
  author  = {Moscoso, Alexis and Leuzy, Antoine and Raket, Lars Lau and Villemagne, Victor L. and Klein, Gregory and Tonietto, Matteo and Olafson, Emily and Baker, Suzanne L. and others},
  title   = {{External Validation of Joint Propagation Model‐Based Tau PET CenTauR units}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_106362},
  url     = {https://doi.org/10.1002/alz70856_106362}
}

@article{mattke2023-37481563,
  author  = {Mattke, S. and Jun, H. and Chen, E. and Liu, Y. and Becker, A. and Wallick, C.},
  title   = {{Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01272-z},
  pmid    = {37481563},
  url     = {https://doi.org/10.1186/s13195-023-01272-z}
}

@article{lee2021-33675684,
  author  = {Lee, S. H. and Meilandt, W. J. and Xie, L. and Gandham, V. D. and Ngu, H. and Barck, K. H. and Rezzonico, M. G. and Imperio, J. and others},
  title   = {{Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology}},
  journal = {Neuron},
  year    = {2021},
  doi     = {10.1016/j.neuron.2021.02.010},
  pmid    = {33675684},
  url     = {https://doi.org/10.1016/j.neuron.2021.02.010}
}

@article{moscoso2025-41434902,
  author  = {Moscoso, Alexis and Leuzy, Antoine and Raket, Lars Lau and Villemagne, Victor L. and Klein, Gregory and Tonietto, Matteo and Olafson, Emily and Baker, Suzanne L. and others},
  title   = {{External Validation of Joint Propagation Model‐Based Tau PET CenTauR units}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70862_109722},
  pmid    = {41434902},
  url     = {https://doi.org/10.1002/alz70862_109722}
}

@article{fox2025-39571734,
  author  = {Fox, J. and Mearns, E. S. and Li, J. and Rosettie, K. L. and Majda, T. and Lin, H. and Kowal, S. L.},
  title   = {{Indirect Costs of Alzheimer's Disease: Unpaid Caregiver Burden and Patient Productivity Loss}},
  journal = {Value in Health},
  year    = {2025},
  doi     = {10.1016/j.jval.2024.10.3851},
  pmid    = {39571734},
  url     = {https://doi.org/10.1016/j.jval.2024.10.3851}
}

@article{meilandt2020-31980586,
  author  = {Meilandt, W. J. and Ngu, H. and Gogineni, A. and Lalehzadeh, G. and Lee, S. H. and Srinivasan, K. and Imperio, J. and Wu, T. and others},
  title   = {{Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2020},
  doi     = {10.1523/jneurosci.1871-19.2019},
  pmid    = {31980586},
  url     = {https://doi.org/10.1523/jneurosci.1871-19.2019}
}

@article{yeh2017-28442216,
  author  = {Yeh, F. L. and Hansen, D. V. and Sheng, M.},
  title   = {{TREM2, Microglia, and Neurodegenerative Diseases}},
  journal = {Trends in molecular medicine},
  year    = {2017},
  doi     = {10.1016/j.molmed.2017.03.008},
  pmid    = {28442216},
  url     = {https://doi.org/10.1016/j.molmed.2017.03.008}
}

@article{bohlen2019-31518519,
  author  = {Bohlen, C. J. and Friedman, B. A. and Dejanovic, B. and Sheng, M.},
  title   = {{Microglia in Brain Development, Homeostasis, and Neurodegeneration}},
  journal = {Annual review of genetics},
  year    = {2019},
  doi     = {10.1146/annurev-genet-112618-043515},
  pmid    = {31518519},
  url     = {https://doi.org/10.1146/annurev-genet-112618-043515}
}

@article{maloney2014-25253696,
  author  = {Maloney, J. A. and Bainbridge, T. and Gustafson, A. and Zhang, S. and Kyauk, R. and Steiner, P. and van der Brug, M. and Liu, Y. and others},
  title   = {{Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein}},
  journal = {The Journal of biological chemistry},
  year    = {2014},
  doi     = {10.1074/jbc.m114.589069},
  pmid    = {25253696},
  url     = {https://doi.org/10.1074/jbc.m114.589069}
}

@article{lee2021-34965428,
  author  = {Lee, S. H. and Rezzonico, M. G. and Friedman, B. A. and Huntley, M. H. and Meilandt, W. J. and Pandey, S. and Chen, Y. J. and Easton, A. and others},
  title   = {{TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease}},
  journal = {Cell reports},
  year    = {2021},
  doi     = {10.1016/j.celrep.2021.110158},
  pmid    = {34965428},
  url     = {https://doi.org/10.1016/j.celrep.2021.110158}
}

@article{spellman2015-25676562,
  author  = {Spellman, D. S. and Wildsmith, K. R. and Honigberg, L. A. and Tuefferd, M. and Baker, D. and Raghavan, N. and Nairn, A. C. and Croteau, P. and others},
  title   = {{Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF}},
  journal = {Proteomics. Clinical applications},
  year    = {2015},
  doi     = {10.1002/prca.201400178},
  pmid    = {25676562},
  url     = {https://doi.org/10.1002/prca.201400178}
}

@article{olafson2025-39746756,
  author  = {Olafson, Emily and Tonietto, Matteo and Klein, Gregory and Teng, Edmond and Stephens, Andrew Wills and Russell, David and Pickthorn, Karen and Bohorquez, Sandra M. Sanabria},
  title   = {{In Vivo Head-to-Head Comparison of [18F]GTP1 with [18F]MK-6240 and [18F]PI-2620 in Alzheimer Disease}},
  journal = {Journal of Nuclear Medicine},
  year    = {2025},
  doi     = {10.2967/jnumed.124.268623},
  pmid    = {39746756},
  url     = {https://doi.org/10.2967/jnumed.124.268623}
}